Daffoworth Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 10-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.09 M
as on 10-12-2024
- Revenue 34.66%
(FY 2023)
- Profit -22.17%
(FY 2023)
- Ebitda -25.77%
(FY 2023)
- Net Worth 15.27%
(FY 2023)
- Total Assets -20.37%
(FY 2023)
About Daffoworth Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.09 M.
Dharmendra Jha and Jha Anita serve as directors at the Company.
- CIN/LLPIN
U24232TG2014PTC095611
- Company No.
095611
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Daffoworth Pharmaceutical Private Limited offer?
Daffoworth Pharmaceutical Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin D3 Tablets & Capsules, Mineral Supplement, Calcium Syrup, Common Disease Medicines, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Daffoworth Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Jha  | Managing Director | 09-Sep-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jha Anita | Director | 09-Sep-2014 | Current |
Financial Performance of Daffoworth Pharmaceutical.
Daffoworth Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.66% increase. The company also saw a substantial fall in profitability, with a 22.17% decrease in profit. The company's net worth Soared by an impressive increase of 15.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daffoworth Pharmaceutical?
Unlock access to Daffoworth Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 May 2024 | ₹6.00 M | Open |
Others Creation Date: 22 Mar 2024 | ₹2.09 M | Open |
How Many Employees Work at Daffoworth Pharmaceutical?
Daffoworth Pharmaceutical has a workforce of 8 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daffoworth Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffoworth Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
